Dipicrylamine Modulates GABAr1 Receptors through Interactions with Residues in the TM4 and Cys-Loop Domains

Agenor Limon-Ruiz, Argel Estrada-Mondragón, Jorge M. Reyes Ruiz, Ricardo Miledi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Dipicrylamine (DPA) is a commonly used acceptor agent in Förster resonance energy transfer experiments that allows the study of high-frequency neuronal activity in the optical monitoring of voltage in living cells. However, DPA potently antagonizes GABAA receptors that contain a1 and b2 subunits by a mechanism which is not clearly understood. In this work, we aimed to determine whether DPA modulation is a general phenomenon of Cys-loop ligand-gated ion channels (LGICs), and whether this modulation depends on particular amino acid residues. For this, we studied the effects of DPA on human homomeric GABAr1, a7 nicotinic, and 5-HT3A serotonin receptors expressed in Xenopus oocytes. Our results indicate that DPA is an allosteric modulator of GABAr1 receptors with an IC50 of 1.6 mM, an enhancer of a7 nicotinic receptors at relatively high concentrations of DPA, and has little, if any, effect on 5-HT3A receptors. DPA antagonism of GABAr1 was strongly enhanced by preincubation, was slightly voltage-dependent, and its washout was accelerated by bovine serum albumin. These results indicate that DPA modulation is not a general phenomenon of LGICs, and structural differences between receptors may account for disparities in DPA effects. In silico modeling of DPA docking to GABAr1, a7 nicotinic, and 5-HT3A receptors suggests that a hydrophobic pocket within the Cys-loop and the M4 segment in GABAr1, located at the extracellular/membrane interface, facilitates the interaction with DPA that leads to inhibition of the receptor. Functional examinations of mutant receptors support the involvement of the M4 segment in the allosteric modulation of GABAr1 by DPA.

Original languageEnglish (US)
Pages (from-to)446-456
Number of pages11
JournalMolecular Pharmacology
Volume89
Issue number4
DOIs
StatePublished - Apr 1 2016
Externally publishedYes

Fingerprint

Ligand-Gated Ion Channels
dipicrylamine
Optical Rotation
Receptors, Serotonin, 5-HT3
Energy Transfer
Nicotinic Receptors
GABA-A Receptors
Bovine Serum Albumin
Xenopus
Computer Simulation
Inhibitory Concentration 50
Oocytes
Amino Acids
Membranes

ASJC Scopus subject areas

  • Medicine(all)
  • Molecular Medicine
  • Pharmacology

Cite this

Dipicrylamine Modulates GABAr1 Receptors through Interactions with Residues in the TM4 and Cys-Loop Domains. / Limon-Ruiz, Agenor; Estrada-Mondragón, Argel; Reyes Ruiz, Jorge M.; Miledi, Ricardo.

In: Molecular Pharmacology, Vol. 89, No. 4, 01.04.2016, p. 446-456.

Research output: Contribution to journalArticle

Limon-Ruiz, Agenor ; Estrada-Mondragón, Argel ; Reyes Ruiz, Jorge M. ; Miledi, Ricardo. / Dipicrylamine Modulates GABAr1 Receptors through Interactions with Residues in the TM4 and Cys-Loop Domains. In: Molecular Pharmacology. 2016 ; Vol. 89, No. 4. pp. 446-456.
@article{222e1f2fa73d45a5aa5b47ebc29cbb41,
title = "Dipicrylamine Modulates GABAr1 Receptors through Interactions with Residues in the TM4 and Cys-Loop Domains",
abstract = "Dipicrylamine (DPA) is a commonly used acceptor agent in F{\"o}rster resonance energy transfer experiments that allows the study of high-frequency neuronal activity in the optical monitoring of voltage in living cells. However, DPA potently antagonizes GABAA receptors that contain a1 and b2 subunits by a mechanism which is not clearly understood. In this work, we aimed to determine whether DPA modulation is a general phenomenon of Cys-loop ligand-gated ion channels (LGICs), and whether this modulation depends on particular amino acid residues. For this, we studied the effects of DPA on human homomeric GABAr1, a7 nicotinic, and 5-HT3A serotonin receptors expressed in Xenopus oocytes. Our results indicate that DPA is an allosteric modulator of GABAr1 receptors with an IC50 of 1.6 mM, an enhancer of a7 nicotinic receptors at relatively high concentrations of DPA, and has little, if any, effect on 5-HT3A receptors. DPA antagonism of GABAr1 was strongly enhanced by preincubation, was slightly voltage-dependent, and its washout was accelerated by bovine serum albumin. These results indicate that DPA modulation is not a general phenomenon of LGICs, and structural differences between receptors may account for disparities in DPA effects. In silico modeling of DPA docking to GABAr1, a7 nicotinic, and 5-HT3A receptors suggests that a hydrophobic pocket within the Cys-loop and the M4 segment in GABAr1, located at the extracellular/membrane interface, facilitates the interaction with DPA that leads to inhibition of the receptor. Functional examinations of mutant receptors support the involvement of the M4 segment in the allosteric modulation of GABAr1 by DPA.",
author = "Agenor Limon-Ruiz and Argel Estrada-Mondrag{\'o}n and {Reyes Ruiz}, {Jorge M.} and Ricardo Miledi",
year = "2016",
month = "4",
day = "1",
doi = "10.1124/mol.116.103432",
language = "English (US)",
volume = "89",
pages = "446--456",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "4",

}

TY - JOUR

T1 - Dipicrylamine Modulates GABAr1 Receptors through Interactions with Residues in the TM4 and Cys-Loop Domains

AU - Limon-Ruiz, Agenor

AU - Estrada-Mondragón, Argel

AU - Reyes Ruiz, Jorge M.

AU - Miledi, Ricardo

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Dipicrylamine (DPA) is a commonly used acceptor agent in Förster resonance energy transfer experiments that allows the study of high-frequency neuronal activity in the optical monitoring of voltage in living cells. However, DPA potently antagonizes GABAA receptors that contain a1 and b2 subunits by a mechanism which is not clearly understood. In this work, we aimed to determine whether DPA modulation is a general phenomenon of Cys-loop ligand-gated ion channels (LGICs), and whether this modulation depends on particular amino acid residues. For this, we studied the effects of DPA on human homomeric GABAr1, a7 nicotinic, and 5-HT3A serotonin receptors expressed in Xenopus oocytes. Our results indicate that DPA is an allosteric modulator of GABAr1 receptors with an IC50 of 1.6 mM, an enhancer of a7 nicotinic receptors at relatively high concentrations of DPA, and has little, if any, effect on 5-HT3A receptors. DPA antagonism of GABAr1 was strongly enhanced by preincubation, was slightly voltage-dependent, and its washout was accelerated by bovine serum albumin. These results indicate that DPA modulation is not a general phenomenon of LGICs, and structural differences between receptors may account for disparities in DPA effects. In silico modeling of DPA docking to GABAr1, a7 nicotinic, and 5-HT3A receptors suggests that a hydrophobic pocket within the Cys-loop and the M4 segment in GABAr1, located at the extracellular/membrane interface, facilitates the interaction with DPA that leads to inhibition of the receptor. Functional examinations of mutant receptors support the involvement of the M4 segment in the allosteric modulation of GABAr1 by DPA.

AB - Dipicrylamine (DPA) is a commonly used acceptor agent in Förster resonance energy transfer experiments that allows the study of high-frequency neuronal activity in the optical monitoring of voltage in living cells. However, DPA potently antagonizes GABAA receptors that contain a1 and b2 subunits by a mechanism which is not clearly understood. In this work, we aimed to determine whether DPA modulation is a general phenomenon of Cys-loop ligand-gated ion channels (LGICs), and whether this modulation depends on particular amino acid residues. For this, we studied the effects of DPA on human homomeric GABAr1, a7 nicotinic, and 5-HT3A serotonin receptors expressed in Xenopus oocytes. Our results indicate that DPA is an allosteric modulator of GABAr1 receptors with an IC50 of 1.6 mM, an enhancer of a7 nicotinic receptors at relatively high concentrations of DPA, and has little, if any, effect on 5-HT3A receptors. DPA antagonism of GABAr1 was strongly enhanced by preincubation, was slightly voltage-dependent, and its washout was accelerated by bovine serum albumin. These results indicate that DPA modulation is not a general phenomenon of LGICs, and structural differences between receptors may account for disparities in DPA effects. In silico modeling of DPA docking to GABAr1, a7 nicotinic, and 5-HT3A receptors suggests that a hydrophobic pocket within the Cys-loop and the M4 segment in GABAr1, located at the extracellular/membrane interface, facilitates the interaction with DPA that leads to inhibition of the receptor. Functional examinations of mutant receptors support the involvement of the M4 segment in the allosteric modulation of GABAr1 by DPA.

UR - http://www.scopus.com/inward/record.url?scp=84962210626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962210626&partnerID=8YFLogxK

U2 - 10.1124/mol.116.103432

DO - 10.1124/mol.116.103432

M3 - Article

VL - 89

SP - 446

EP - 456

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 4

ER -